Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan

CONTEXT: Somapacitan is a long-acting growth hormone (GH) in development for once-weekly treatment of GH deficiency (GHD). Optimal monitoring of insulin-like growth factor-I (IGF-I) levels must account for weekly IGF-I fluctuations following somapacitan administration. OBJECTIVE: To develop and asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Juul Kildemoes, Rasmus, Højby Rasmussen, Michael, Agersø, Henrik, Overgaard, Rune Viig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823237/
https://www.ncbi.nlm.nih.gov/pubmed/33313798
http://dx.doi.org/10.1210/clinem/dgaa775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823237/
https://www.ncbi.nlm.nih.gov/pubmed/33313798
http://dx.doi.org/10.1210/clinem/dgaa775

Ejemplares similares